FOXO1 is transcriptional regulator of malignant B-cell surface antigen CD20, the target for therapeutic monoclonal antibodies.
Authors: Pyrzynska B., Zerrouqi A., Dwojak M., Morlino G., Zapala P., Miazek N., Zagozdzon A., Bojarczuk K., Bobrowicz M., Siernicka M., Machnicki M.M., Barankiewicz J., Lech-Maranda E., Juszczynski P., Calado D., Golab J., Winiarska M.
Published in: AACR Special Conference on Tumor Immunology and Immunotherapy
Publication type: conference